机译:尿激酶型纤溶酶原激活物受体和EGF受体变体III之间的串扰支持胶质母细胞瘤细胞的存活和生长
Departments of Pathology, University of California at San Diego, La Jolla, CA 92093;
Departments of Pathology, University of California at San Diego, La Jolla, CA 92093;
Departments of Medicine, University of California at San Diego, La Jolla, CA 92093,Departments of Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093;
Departments of Medicine, University of California at San Diego, La Jolla, CA 92093,Departments of Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA 92093;
Departments of Pathology, University of California at San Diego, La Jolla, CA 92093;
Departments of Pathology, University of California at San Diego, La Jolla, CA 92093;
c-src; STAT33; cell death; RNA interference;
机译:鞘氨醇-1-磷酸和白介素-1独立调节胶质母细胞瘤细胞中的纤溶酶原激活物抑制剂-1和尿激酶型纤溶酶原激活物受体的表达:对侵袭性的影响。
机译:胶质母细胞瘤针对表皮生长因子受体变体III(EGFRvIII)的嵌合抗原受体(CAR)T细胞免疫疗法的开发
机译:表皮生长因子调节前列腺癌细胞的侵袭性,调节尿激酶型纤溶酶原激活剂的活性。 EGF受体抑制可能阻止肿瘤细胞的传播。
机译:抑制肿瘤相关的尿激酶型纤溶酶原激活系统:高水平合成在体外和体内卵巢癌细胞中可溶性尿激酶受体的影响
机译:雌激素受体β:对血管平滑肌细胞中尿激酶型纤溶酶原激活剂的影响。
机译:尿激酶型纤溶酶原激活物受体和EGF受体变体III之间的串扰支持胶质母细胞瘤细胞的存活和生长
机译:尿激酶型纤溶酶原激活物受体和EGF受体变体III之间的串扰支持胶质母细胞瘤细胞的存活和生长